Timothy E Gressett
Overview
Explore the profile of Timothy E Gressett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talkington G, Kolluru P, Gressett T, Ismael S, Meenakshi U, Acquarone M, et al.
Front Neurol
. 2025 Mar;
15:1465787.
PMID: 40046430
One lingering effect of the COVID-19 pandemic created by SARS-CoV-2 is the emergence of Long COVID (LC), characterized by enduring neurological sequelae affecting a significant portion of survivors. This review...
2.
Molecular interactions between perlecan LG3 and the SARS-CoV-2 spike protein receptor binding domain
Gressett T, Hossen M, Talkington G, Volic M, Perez H, Tiwari P, et al.
Protein Sci
. 2023 Nov;
33(1):e4843.
PMID: 37996967
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a global health crisis with significant clinical morbidity and mortality. While angiotensin-converting enzyme 2 (ACE2) is the primary receptor for viral entry,...
3.
Lavorgna T, Gressett T, Chastain W, Bix G
Front Physiol
. 2023 Jun;
14:1189731.
PMID: 37324385
Perlecan is a 500 kDa proteoglycan residing in the extracellular matrix of endothelial basement membranes with five distinct protein domains and three heparan sulfate chains. The complex structure of perlecan...
4.
Gressett T, Leist S, Ismael S, Talkington G, Dinnon K, Baric R, et al.
bioRxiv
. 2023 Mar;
PMID: 36993423
The novel coronavirus SARS-CoV-2 has caused significant global morbidity and mortality and continues to burden patients with persisting neurological dysfunction. COVID-19 survivors develop debilitating symptoms to include neuro-psychological dysfunction, termed...
5.
Amruta N, Maness N, Gressett T, Tsuchiya Y, Kishi M, Bix G
PLoS One
. 2023 Feb;
18(2):e0276578.
PMID: 36753524
Effective measures are needed to prevent the spread and infectivity of SARS-CoV-2 that causes COVID-19. Chemical inactivation may help to prevent the spread and transmission of this and other viruses....
6.
Amruta N, Ismael S, Leist S, Gressett T, Srivastava A, Dinnon 3rd K, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680154
Increasing evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection impacts neurological function both acutely and chronically, even in the absence of pronounced respiratory distress. Developing clinically relevant...
7.
Gressett T, Nader D, Robles J, Buranda T, Kerrigan S, Bix G
Front Cell Infect Microbiol
. 2022 May;
12:892323.
PMID: 35619646
No abstract available.
8.
Amruta N, Engler-Chiurazzi E, Murray-Brown I, Gressett T, Biose I, Chastain W, et al.
Life Sci
. 2021 Aug;
284:119881.
PMID: 34389403
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an infectious disease that has spread worldwide. Current treatments are limited in both availability and efficacy, such that improving our understanding of...
9.
Amruta N, Chastain W, Paz M, Solch R, Murray-Brown I, Befeler J, et al.
Cytokine Growth Factor Rev
. 2021 Mar;
58:1-15.
PMID: 33674185
SARS-CoV-2 is a novel coronavirus that severely affects the respiratory system, is the cause of the COVID-19 pandemic, and is projected to result in the deaths of 2 million people...